ReviewRheumatology (Oxford, England)2017

Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases.

Sabrina Fechtner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.